Physician
Ammar Sukari, M.D.
According to 2025 Medicare claims, Ammar Sukari, M.D. (NPI: 1013960384) practices medical oncology in the Detroit-Dearborn-Livonia, MI market, with the plurality of this provider's patient population coming from Wayne, MI. This provider's primary affiliated billing organization is BARBARA ANN KARMANOS CANCER INSTITUTE (NPI: 1386060226; TIN: 38-1613280) and primary practice location at 48201-2013.
Sukari's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 137 traditional Medicare patients, billed 518 HCPCS/CPT codes, and received $50,719 in Medicare payments. The top billing code was 99205 (New patient office or other outpatient visit with a high level of medical decision making, if using time, 60 minutes or more). Part D data shows 645 prescription claims across 133 beneficiaries totaling $1,975,915 in drug costs, led by Mekinist (Trametinib Dimethyl Sulfoxide). DME data shows 135 claims. Open Payments data shows 330 records totaling $1,213,292. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.
Over the past 10 years, this provider's Medicare Part B carrier billing has moved from a higher plateau to a lower plateau, from $161,850 to $50,719. In contrast, Part D prescription costs have risen steadily, from $941,932 to $1,975,915. For DME billing, this smaller-volume category started with an early spike, then settled into a lower baseline, moving from $8,005 to $3,422.